Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.059 | 0.7 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.064 | 0.7 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.065 | 0.7 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |